These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 33112582)
1. Does PET/CT Aid in Detecting Primary Carcinoma in Patients with Skeletal Metastases of Unknown Primary? Lawrenz JM; Gordon J; George J; Haben C; Rubin BP; Ilaslan H; Mesko NW; Nystrom LM Clin Orthop Relat Res; 2020 Nov; 478(11):2451-2457. PubMed ID: 33112582 [TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
3. Is Skeletal Imaging Essential in the Staging Workup for Conventional Chondrosarcoma? Gulia A; Kurisunkal V; Puri A; Purandare N; Gupta S; Rangarajan Drm V Clin Orthop Relat Res; 2020 Nov; 478(11):2480-2484. PubMed ID: 32567825 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases. Chang CY; Gill CM; Joseph Simeone F; Taneja AK; Huang AJ; Torriani M; Bredella MA Acta Radiol; 2016 Jan; 57(1):58-65. PubMed ID: 25533313 [TBL] [Abstract][Full Text] [Related]
5. Role of Budak E; Yanarateş A Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):14-19. PubMed ID: 31744788 [TBL] [Abstract][Full Text] [Related]
6. Lengana T; Lawal IO; Boshomane TG; Popoola GO; Mokoala KMG; Moshokoa E; Maes A; Mokgoro NP; Van de Wiele C; Vorster M; Sathekge MM Clin Genitourin Cancer; 2018 Oct; 16(5):392-401. PubMed ID: 30120038 [TBL] [Abstract][Full Text] [Related]
7. Role of 18-Fludeoxyglucose positron emission tomography-computed tomography and subsequent panendoscopy in head and neck squamous cell carcinoma of unknown primary. Mani N; George MM; Nash L; Anwar B; Homer JJ Laryngoscope; 2016 Jun; 126(6):1354-8. PubMed ID: 26671043 [TBL] [Abstract][Full Text] [Related]
8. [The role of PET-CT in detecting unknown primary tumour in patients with cervical lymph node metastases]. Fülöp M; Kásler M; Remenár E; Lengyel Z; Borbély K Magy Onkol; 2012 May; 56(2):84-92. PubMed ID: 22629545 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of Wolpert F; Weller M; Berghoff AS; Rushing E; Füreder LM; Petyt G; Leske H; Andratschke N; Regli L; Neidert MC; Stupp R; Stahel R; Dummer R; Frauenfelder T; Roth P; Reyns N; Kaufmann PA; Preusser M; Le Rhun E Eur J Cancer; 2018 Jun; 96():64-72. PubMed ID: 29677642 [TBL] [Abstract][Full Text] [Related]
11. Hybrid imaging for detection of carcinoma of unknown primary: A preliminary comparison trial of whole-body PET/MRI versus PET/CT. Ruhlmann V; Ruhlmann M; Bellendorf A; Grueneisen J; Sawicki LM; Grafe H; Forsting M; Bockisch A; Umutlu L Eur J Radiol; 2016 Nov; 85(11):1941-1947. PubMed ID: 27776644 [TBL] [Abstract][Full Text] [Related]
12. Value of 18F-FDG PET/CT in patients with hepatic metastatic carcinoma of unknown primary. Li Y; Li F; Li X; Qu L; Han J Medicine (Baltimore); 2020 Dec; 99(50):e23210. PubMed ID: 33327238 [TBL] [Abstract][Full Text] [Related]
13. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography. Ak I; Sivrikoz MC; Entok E; Vardareli E Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657 [TBL] [Abstract][Full Text] [Related]
14. Whole-body Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514 [TBL] [Abstract][Full Text] [Related]
15. The impact of 18F-FDG PET/CT in the clinical management of patients with lymph node metastasis of unknown primary origin. Nikolova PN; Hadzhiyska VH; Mladenov KB; Ilcheva MG; Veneva S; Grudeva VV; Dineva SE; Asenov YN Neoplasma; 2021 Jan; 68(1):180-189. PubMed ID: 32880466 [TBL] [Abstract][Full Text] [Related]
16. Sensitivity of [18F]FDG PET/CT and classification of the primary tumor site in patients with carcinoma of unknown primary. Atilgan HI; Yalcin H Nucl Med Rev Cent East Eur; 2022; 25(1):1-5. PubMed ID: 35137930 [TBL] [Abstract][Full Text] [Related]
17. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary. Han A; Xue J; Hu M; Zheng J; Wang X Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050 [TBL] [Abstract][Full Text] [Related]
19. Comparison of 18F-Fluciclovine PET/CT and 99mTc-MDP bone scan in detection of bone metastasis in prostate cancer. Chen B; Wei P; Macapinlac HA; Lu Y Nucl Med Commun; 2019 Sep; 40(9):940-946. PubMed ID: 31343613 [TBL] [Abstract][Full Text] [Related]
20. The value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of an unknown primary: diagnosis and follow-up. Yapar Z; Kibar M; Yapar AF; Paydas S; Reyhan M; Kara O; Buyukdereli G; Aydin M; Kelle AP; Unal I; Disel U; Yavuz S; Sahin B; Erkisi M Nucl Med Commun; 2010 Jan; 31(1):59-66. PubMed ID: 19952921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]